Invesco’s $3 Billion Magic Act: Preferred Stock, 40% Margins, and a Fee Yield That Won’t Stop Sliding

The asset manager printed its best adjusted margin since 2021 and bought back more preferred stock—but the mix shift to ETFs and money funds is the tell.

IVZ · Earnings Call · 2026-10-27

A 40.7% margin that management won’t let you keep

Invesco’s third quarter was, on the surface, a clean operating beat. The company generated “over $100 billion of net long-term inflows through the first nine months of the year, representing a 6.5% annualized organic growth rate” — Andrew Schlossberg, President and Chief Executive Officer · 2026-10-27, and adjusted operating margin hit 40.7%, the highest since 2021. Yet CEO Andrew Schlossberg and CFO Allison Dukes spent much of the call steering expectations lower. “Our focus is on maintaining and sustaining that margin in the high 30s” — Allison Dukes, Chief Financial Officer · 2026-10-27, Dukes said—even after a quarter that printed north of 40%. That is not a contradiction so much as a warning: the margin is real, but it is being helped by scale in lower-fee products, disciplined expenses, and a market that has been constructive. The stock’s tape is already skeptical. IVZ is down 14.7% from its late-August peak and roughly flat over the past 90 trading days, despite the improving fundamental print. The market is treating 40.7% as a cyclical high, not a new baseline. The latest filed quarter, Q2 2026, showed total revenue of $1.8B, up 20% year over year, with a 24.9% operating margin. The adjusted number is better because it strips out items the company considers non-core, but the gap is a reminder that the headline margin is not the whole P&L. The stock still trades at 8.0x price to operating income, well below its long-run peaks.

The real new news is the preferred stock

The incremental story this quarter is capital structure. Invesco announced another $1.5B repurchase of preferred stock from MassMutual, bringing total repurchases to $3B since May 2025 and leaving just $1B outstanding. The deal was funded with a $1.5B five-year term loan—a floating rate bank facility currently priced in the 5.35%-5.4% range based on SOFR.

We funded the purchase with a $1.5 billion five-year floating rate bank term loan that currently has a rate in the 5.35%-5.4% range based on SOFR today, for an approximate after-tax cost in the 4%-4.05% range. This compares favorably to the fixed 5.9% dividend on the preferred stock, which is not tax-deductible.
Allison Dukes, Chief Financial Officer · 2026-10-27

The math is straightforward: replace a non-tax-deductible 5.9% preferred dividend with cheaper, tax-deductible debt. Management expects the transaction to be “earnings accretive in 2027, and the accretion will increase over time as we pay down the term loan” — Allison Dukes, Chief Financial Officer · 2026-10-27. The company pegs 2027 EPS accretion at $0.17, rising to a $0.41 run rate once the loans are fully repaid—expected in 2031. This is a change in pace from July, when Dukes said the company wanted to “continue to work that down just a bit before trying to address more of the preferred” — Allison Dukes, Chief Financial Officer · 2026-07-28. Conditions evidently improved: the 12.5% premium paid to MassMutual is lower than prior repurchases, reflecting higher market rates. But the trade-off is fresh floating-rate exposure and a near-term leverage bump excluding preferred, even as the inclusive leverage ratio improved from 2.5x to 1.6x over the past year. This is a real EPS catalyst, but it is financial engineering, not organic growth.

The mix shift is the recurring villain

The operating engine is still working, but the revenue yield is grinding lower. Q3 net revenue yield was 21.5 basis points, and the exit yield was 21.3—down from 22.0 at the end of Q2. The culprit is the same mix shift management has discussed for several quarters: strong demand for lower-fee ETFs, the QQQ suite, and money market funds. Money market inflows were $53B in the quarter, helping liquidity AUM reach $262B, while ETF and index AUM hit a record $775B. That is good for scale and bad for fee yield. Dukes was explicit that the Canadian sale cost about 0.2 of a basis point, while “0.7 or so would've been really just driven by mix shift” — Allison Dukes, Chief Financial Officer · 2026-10-27. The market fund boom is particularly double-edged: it brings assets and revenue, but at a lower yield than active equity. The question for investors is whether 6.3% organic growth can outrun that compression. For now, it can—current-quarter net revenue rose 16% year over year—but the trend is why management refuses to promise a 40% margin.

Tokenization, models, and the next wrapper

The forward-looking answer is distribution. Invesco is leaning into Model portfolios, now over $20B in assets, alongside a $41B SMA platform and $30B in active ETFs. But the most company-unique theme in the call was tokenization. “We think the tokenized fund market is going to continue to grow, and we think it is important” — Andrew Schlossberg, President and Chief Executive Officer · 2026-10-27, Schlossberg said, pointing to the firm’s first tokenized money market fund with Superstate—roughly $1B—and potential stablecoin reserve money market fund tokenizations. This is not entirely new: on the July call, management described taking over that “$1 billion tokenized US Treasury fund” — Andrew Schlossberg, Chief Executive Officer · 2026-07-28 as an important first foray. What is new is the breadth of ambition—ETFs, traditional funds, and on-chain cash equivalents. It is early and small relative to $2.5T in AUM, but it is the kind of keyword that can become a real differentiator if the wrapper shift accelerates.

Bottom line

Invesco’s quarter is a strong operating print wrapped in a balance-sheet optimization. The core franchise is working: global organic growth, scale in ETFs, a record China JV, and improving margins. But the fee yield is still sliding, the preferred buyback is partly financial engineering, and the stock is not rewarding the headline. Management’s high-30s anchor is a deliberate cushion, not a lack of ambition—Dukes said there is “no ceiling on ourselves whatsoever” — Allison Dukes, Chief Financial Officer · 2026-10-27—but investors will want proof that net revenue yield can stabilize before they pay up for the EPS accretion. The next leg has to come from organic mix, model portfolios, private markets, and tokenization, not from buying back preferred stock. Until then, IVZ looks like a company doing the right things, with a market that is not yet convinced the good news is durable.